154 related articles for article (PubMed ID: 32766146)
21. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
[TBL] [Abstract][Full Text] [Related]
22.
Svasdisant P; Glomglao W; Siraprapapat P; Inthararujikul W; Tachavanich K; Boonthimat C; Ardsiri S; Chansing K; Sriprach S; Tongsai S; Sinlapamongkolkul P; Sanpakit K; Buaboonnam J
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023024. PubMed ID: 36908869
[TBL] [Abstract][Full Text] [Related]
23. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
Wall GC; Muktar H; Effken C; Mahajan PB
Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
[TBL] [Abstract][Full Text] [Related]
24. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Melachuri S; Gandrud L; Bostrom B
Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
[TBL] [Abstract][Full Text] [Related]
25. Homozygous mutation in NUDT15 in childhood acute lymphoblastic leukemia with increased susceptibility to mercaptopurine toxicity: A case report.
Cheng J; Zhang H; Ma HZ; Li J
Exp Ther Med; 2019 May; 17(5):4285-4288. PubMed ID: 31007757
[TBL] [Abstract][Full Text] [Related]
26. The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
Rudin S; Marable M; Huang RS
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):82-93. PubMed ID: 28391009
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of allopurinol induced TPMT inhibition.
Blaker PA; Arenas-Hernandez M; Smith MA; Shobowale-Bakre EA; Fairbanks L; Irving PM; Sanderson JD; Marinaki AM
Biochem Pharmacol; 2013 Aug; 86(4):539-47. PubMed ID: 23770457
[TBL] [Abstract][Full Text] [Related]
28. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
Abdelaziz DH; Elhosseiny NM; Khaleel SA; Sabry NA; Attia AS; El-Sayed MH
Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
[TBL] [Abstract][Full Text] [Related]
29. Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
Meijer B; Seinen ML; Leijte NN; Mulder CJ; van Bodegraven AA; de Boer NK
Ther Drug Monit; 2016 Aug; 38(4):463-70. PubMed ID: 27158876
[TBL] [Abstract][Full Text] [Related]
30. Mercaptopurine metabolite results in clinical gastroenterology practice.
Bloomfeld RS; Onken JE
Aliment Pharmacol Ther; 2003 Jan; 17(1):69-73. PubMed ID: 12492734
[TBL] [Abstract][Full Text] [Related]
31. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
Cuffari C; Théorêt Y; Latour S; Seidman G
Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
[TBL] [Abstract][Full Text] [Related]
32. Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?
Lennard L; Davies HA; Lilleyman JS
Br J Cancer; 1993 Jul; 68(1):186-90. PubMed ID: 8318412
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.
Adamson PC; Balis FM; Arndt CA; Holcenberg JS; Narang PK; Murphy RF; Gillespie AJ; Poplack DG
Cancer Res; 1991 Nov; 51(22):6079-83. PubMed ID: 1933871
[TBL] [Abstract][Full Text] [Related]
34. Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia.
Cho EM; Moon JE; Lee SJ; Ko CW
Ann Pediatr Endocrinol Metab; 2018 Dec; 23(4):226-228. PubMed ID: 30599485
[TBL] [Abstract][Full Text] [Related]
35. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
Rahhal RM; Bishop WP
Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
[TBL] [Abstract][Full Text] [Related]
36. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
Serpico MR; Maltz R; Crandall W; Bricker J; Dotson JL; Kim SC; Boyle B
J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):341-345. PubMed ID: 29601433
[TBL] [Abstract][Full Text] [Related]
37. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
[TBL] [Abstract][Full Text] [Related]
38. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.
Azimi F; Mortazavi Y; Alavi S; Khalili M; Ramazani A
Leuk Res; 2015 Oct; 39(10):1048-54. PubMed ID: 26242828
[TBL] [Abstract][Full Text] [Related]
39. Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion.
Zimm S; Ettinger LJ; Holcenberg JS; Kamen BA; Vietti TJ; Belasco J; Cogliano-Shutta N; Balis F; Lavi LE; Collins JM
Cancer Res; 1985 Apr; 45(4):1869-73. PubMed ID: 4038917
[TBL] [Abstract][Full Text] [Related]
40. Palliative cytoreduction in refractory acute leukemia: a retrospective study of 57 adult patients.
Funke I; Wiesneth M; Platow S; Kubanek B
Ann Hematol; 2000 Mar; 79(3):132-7. PubMed ID: 10803935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
